BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• 

  Deals

  Novartis Considers Selling Its $1B+ Dermatology Generics Biz

  Days after plunking down $3.9B+ for AAA, Novartis may be looking to divest itself of its generic dermatology drug business.

  November 1, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  Big Changes are Coming as Allergan Looks to Cut Costs, Sell Teva Stock

  Allergan released its third-quarter financials, with mixed results and plans to make fairly major changes.

  November 1, 2017

   · 

  3 min read

   · 

  Mark Terry
• 

  Drug Development

  Tweaks to bluebird bio’s Gene Therapy Approach May be Working

  Bluebird is making forays into the CAR-T immuno-oncology market, although it has yet to bring a product to market.

  November 1, 2017

   · 

  3 min read

   · 

  Mark Terry
• 

  Policy

  Top Mylan Exec Targeted in Price-Fixing Suit

  Mylan’s second-ranked exec allegedly took an active role in a vast and “sinister” price-fixing conspiracy among global makers of generic pills.

  November 1, 2017

   · 

  1 min read
• 

  Biotech Bay

  Bay Area’s AvidBiotics Splits Into Two Biotech Companies

  AvidBiotics is splitting into two separate companies and has developed two separate but similar technology platforms.

  November 1, 2017

   · 

  2 min read

   · 

  Mark Terry
• 

  Business

  Novartis Scientist Wounded in NYC Terrorist Attack That Killed Eight People

  The scientist was among the nearly one dozen people injured on Oct. 31.

  November 1, 2017

   · 

  2 min read

   · 

  Alex Keown
• Business

  Arbutus Announces Conference Call to Provide a Corporate Update and Third Quarter 2017 Financial Results

  The company will host a conference call to provide a corporate update.

  November 1, 2017

   · 

  1 min read
• Dotmatics Announces Immediate Availability of 5.2 Informatics Suite With Major New Chemistry, Reaction Workflows and Register Capabilities

  Dotmatics announced Version 5.2, a new release of the company’s informatics suite designed to enhance the end user experience and make scientists more productive.

  November 1, 2017

   · 

  3 min read
• 

  Drug Development

  AstraZeneca’s Asthma Drug Flunks Two Late-Stage Trials

  Astra and its MedImmune division announced that two Phase III clinical trials of tralokinumab for severe, uncontrolled asthma failed to meet their primary endpoints.

  November 1, 2017

   · 

  3 min read

   · 

  Mark Terry
• 

  Deals

  Halyard Health Unloads S&IP Biz to Owens & Minor for $710M

  Shares of Halyard Health are up more than 12 percent after the company announced it was selling its S&IP business to Owens & Minor for $710M.

  November 1, 2017

   · 

  2 min read

   · 

  Alex Keown